A new study, published in the Journal of Nanobiotechnology, indicated that rice bran-derived nanoparticles (rbNPs) showed promise of having excellent anti-cancer activity in mice. Additionally, unlike many cancer medications, rbNPs were not toxic to noncancerous cells.
While the researchers described the anti-cancer effect as “strong,” clinical trials are necessary to determine if they have a similar benefit in humans.
Promising Findings
Rice bran is a by-product of the rice-milling process. Although most of it is discarded during manufacturing, it contains nutrients, including vitamins, minerals, proteins, and essential fatty acids. It is also a source of compounds with anti-cancer properties, such as gamma-oryzanol, gamma-tocotrienol, and tricin. Nanoparticles are tiny particles used to deliver a substance to tissues.
Mary West
Author
Mary West is a freelance writer whose work has appeared in Medical News Today, Small Business Today Magazine, and other publications. She holds two bachelor of science degrees from the University of Louisiana at Monroe.